Altered posttranslational modification on U1 small nuclear ribonucleoprotein 68k in systemic autoimmune diseases detected by 2D Western blot.
Altered posttranslational modification on U1 small nuclear ribonucleoprotein 68k in systemic autoimmune diseases detected by 2D Western blot.
复制标题
通过 2D Western blot 检测系统性自身免疫性疾病中 U1 小核核糖核蛋白 68k 翻译后修饰的改变。
DOI:
10.1002/elps.201200058
复制
发表时间:
2012
期刊:
影响因子:
2.9
通讯作者:
Tomohiro Kato
中科院分区:
文献类型:
--
作者:
Kouhei Nagai; Mitsumi Arito;Yukiko Takakuwa;Seido Ooka;Toshiyuki Sato;Manae S Kurokawa;Kazuki Okamoto;Teisuke Uchida;Naoya Suematsu;Tomohiro Kato
Anti‐ribonucleoprotein (anti‐RNP) antibodies are one of the representative autoantibodies detectable in patients with systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD). Generally, posttranslational modifications (PTMs) on autoantigens are proposed to be involved in the production of autoantibodies. In this study, we tried to detect the alteration in PTMs on a U1 small nuclear RNP 68k subunit (U1‐68k), a major antigen of anti‐RNP antibodies. Peripheral blood mononuclear cells (PBMCs) were obtained from patients with MCTD, SLE, and rheumatoid arthritis (RA), and from healthy donors. U1‐68ks in the PBMCs were detected by 2D Western blot (WB), where extracted nuclear proteins were separated by 2DE, followed by the detection of U1‐68k using WB. More than 20 PTM isoforms were detected with different molecular weights of 65.0 , 66.5, and 68.0kDa, and different pIs between 6.0 and 8.5. Importantly, the relative intensity of the spot with 66.5 kDa and pI7.5 was significantly increased in the MCTD and SLE groups compared to the RA and healthy groups. Further, this U1‐68k isoform, in particular, in its RS domain, was found to have significantly decreased phosphorylation compared to the other isoforms. The PTM alternation may be one of the steps to generate the anti‐RNP antibodies.